In April 2026 the FDA removed BPC-157 along with a number of other peptides, TB-500 among them from the Section 503A Category 2 list that had restricted compounding, and a Pharmacy Compounding Advisory Committee meeting on 2324 July 2026 is due to consider them further
AHK-Cu Peptide and Alopecia Research The study examined the potential of two formulations containing growth factors and peptides such as vascular endothelial growth factor, basic fibroblast growth factor, insulin-like growth factor-1, keratinocyte growth factor, and copper tripeptide 1 and related peptides such as AHK-Cu, suspended in a sterile vehicle
In the present study, the cecal microbiome differed significantly across treatment groups, despite tightly controlling for several variables known to alter the microbiome in rodents
Others add B12 later, once the dose has stabilized
The key point: B12 treatment reliably helps people who are actually low in B12
Symptoms include dizziness, weakness, confusion, and irritability
